MiRNA-891a-5p mediates HIV-1 Tat and KSHV Orf-K1 synergistic induction of angiogenesis by activating NF-κB signaling

Nucleic Acids Research

Volumn 43, Issue 19, 2015, Pages 9362-9378

  Yao, Shuihong ^a,b   Hu, Minmin ^a   Hao, Tingting ^c   Li, Wan ^a   Xue, Xue ^a   Xue, Min ^a   Zhu, Xiaofei ^a   Zhou, Feng ^a   Qin, Di ^a   Yan, Qin ^a   Zhu, Jianzhong ^d   Gao, Shou Jiang ^e   Lu, Chun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Quzhou College of Technology   (China)

^c XUZHOU MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 891A 5P; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; I KAPPA B KINASE ALPHA; MEMBRANE PROTEIN; NFKBIA PROTEIN, HUMAN; NFKBIA PROTEIN, MOUSE; ORF-K1 PROTEIN, HUMAN HERPESVIRUS 8; VIRUS ENVELOPE PROTEIN;

3' UNTRANSLATED REGION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CHORIOALLANTOIS; CONTROLLED STUDY; GENE EXPRESSION; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MALE; MICROTUBULE; MOUSE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CELL LINE; CHICK EMBRYO; GENETICS; HUMAN; METABOLISM; NUDE MOUSE; ULTRASTRUCTURE;

ANIMALS; CARCINOGENESIS; CELL LINE; CELL PROLIFERATION; CHICK EMBRYO; HIV-1; HUMANS; I-KAPPA B PROTEINS; MALE; MEMBRANE PROTEINS; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; MICROTUBULES; NEOVASCULARIZATION, PHYSIOLOGIC; NF-KAPPA B; NF-KAPPAB INHIBITOR ALPHA; SIGNAL TRANSDUCTION; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; VIRAL ENVELOPE PROTEINS;

EID: 84959386712     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv988     Document Type: Article

References (83)

1. Chang,Y., Cesarman,E., Pessin,M.S., Lee,F., Culpepper,J., Knowles,D.M. and Moore,P.S. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science, 266, 1865-1869.
2. Ganem,D. (2006) KSHV infection and the pathogenesis of Kaposi's sarcoma. Annu. Rev. Pathol., 1, 273-296.
3. Cai,Q., Verma,S.C., Lu,J. and Robertson,E.S. (2010) Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis. Adv. Virus Res., 78, 87-142.
4. Mesri,E.A., Cesarman,E. and Boshoff,C. (2010) Kaposi's sarcoma and its associated herpesvirus. Nat. Rev. Cancer, 10, 707-719.
5. Cousins,E. and Nicholas,J. (2014) Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication. Recent Results Cancer Res., 193, 227-268.
6. Dai,L., Bratoeva,M., Toole,B.P., Qin,Z. and Parsons,C. (2012) KSHV activation of VEGF secretion and invasion for endothelial cells is mediated through viral upregulation of emmprin-induced signal transduction. Int. J. Cancer, 131, 834-843.
7. Aoki,Y. and Tosato,G. (2001) Vascular endothelial growth factor/vascular permeability factor in the pathogenesis of primary effusion lymphomas. Leuk. Lymphoma, 41, 229-237.
8. Samaniego,F., Markham,P.D., Gendelman,R., Watanabe,Y., Kao,V., Kowalski,K., Sonnabend,J.A., Pintus,A., Gallo,R.C. and Ensoli,B. (1998) Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development. Am. J. Pathol., 152, 1433-1443.
9. Barillari,G., Sgadari,C., Palladino,C., Gendelman,R., Caputo,A., Morris,C.B., Nair,B.C., Markham,P., Nel,A., Sturzl,M. et al. (1999) Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin. J. Immunol., 163, 1929-1935.
10. Wang,L., Dittmer,D.P., Tomlinson,C.C., Fakhari,F.D. and Damania,B. (2006) Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus. Cancer Res., 66, 3658-3666.
11. Lagunoff,M., Majeti,R., Weiss,A. and Ganem,D. (1999) Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus. Proc. Natl. Acad. Sci. U.S.A., 96, 5704-5709.
12. Lee,B.S., Connole,M., Tang,Z., Harris,N.L. and Jung,J.U. (2003) Structural analysis of the Kaposi's sarcoma-associated herpesvirus K1 protein. J. Virol., 77, 8072-8086.
13. Wang,L., Wakisaka,N., Tomlinson,C.C., DeWire,S.M., Krall,S., Pagano,J.S. and Damania,B. (2004) The Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) K1 protein induces expression of angiogenic and invasion factors. Cancer Res., 64, 2774-2781.
14. Wang,L. and Damania,B. (2008) Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells. Cancer Res., 68, 4640-4648.
15. Lee,H., Veazey,R., Williams,K., Li,M., Guo,J., Neipel,F., Fleckenstein,B., Lackner,A., Desrosiers,R.C. and Jung,J.U. (1998) Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat Med, 4, 435-440.
16. Bhatt,A.P. and Damania,B. (2012) AKTivation of PI3K/AKT/mTOR signaling pathway by KSHV. Front. Immunol, 3, 401.
17. Guilluy,C., Zhang,Z., Bhende,P.M., Sharek,L., Wang,L., Burridge,K. and Damania,B. (2011) Latent KSHV infection increases the vascular permeability of human endothelial cells. Blood, 118, 5344-5354.
18. Mercader,M., Taddeo,B., Panella,J.R., Chandran,B., Nickoloff,B.J. and Foreman,K.E. (2000) Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells. Am. J. Pathol., 156, 1961-1971.
19. Morris,A.K. and Valley,A.W. (1996) Overview of the management of AIDS-related Kaposi's sarcoma. Ann. Pharmacother., 30, 1150-1163.
20. Ensoli,B., Barillari,G., Salahuddin,S.Z., Gallo,R.C. and Wong-Staal,F. (1990) Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature, 345, 84-86.
21. Zhu,X., Guo,Y., Yao,S., Yan,Q., Xue,M., Hao,T., Zhou,F., Zhu,J., Qin,D. and Lu,C. (2014) Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway. Oncogene, 33, 1986-1996.
22. Zhou,F., Xue,M., Qin,D., Zhu,X., Wang,C., Zhu,J., Hao,T., Cheng,L., Chen,X., Bai,Z. et al. (2013) HIV-1 Tat Promotes Kaposi's Sarcoma-Associated Herpesvirus (KSHV) vIL-6-Induced Angiogenesis and Tumorigenesis by Regulating PI3K/PTEN/AKT/GSK-3beta Signaling Pathway. PLoS One, 8, e53145.
23. Aoki,Y. and Tosato,G. (2007) Interactions between HIV-1 Tat and KSHV. Curr. Top. Microbiol. Immunol., 312, 309-326.
24. Qiao,X., He,B., Chiu,A., Knowles,D.M., Chadburn,A. and Cerutti,A. (2006) Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nat. Immunol., 7, 302-310.
25. Li,J.C., Yim,H.C. and Lau,A.S. (2010) Role of HIV-1 Tat in AIDS pathogenesis: its effects on cytokine dysregulation and contributions to the pathogenesis of opportunistic infection. AIDS, 24, 1609-1623.
26. Cafaro,A., Caputo,A., Fracasso,C., Maggiorella,M.T., Goletti,D., Baroncelli,S., Pace,M., Sernicola,L., Koanga-Mogtomo,M.L., Betti,M. et al. (1999) Control of SHIV-89.6P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine. Nat. Med., 5, 643-650.
27. Huigen,M.C., Kamp,W. and Nottet,H.S. (2004) Multiple effects of HIV-1 trans-activator protein on the pathogenesis of HIV-1 infection. Eur. J. Clin. Invest., 34, 57-66.
28. Faller,E.M., Sugden,S.M., McVey,M.J., Kakal,J.A. and MacPherson,P.A. (2010) Soluble HIV Tat protein removes the IL-7 receptor alpha-chain from the surface of resting CD8 T cells and targets it for degradation. J. Immunol., 185, 2854-2866.
29. Chang,H.C., Samaniego,F., Nair,B.C., Buonaguro,L. and Ensoli,B. (1997) HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region. AIDS, 11, 1421-1431.
30. Wood,N.H. and Feller,L. (2008) The malignant potential of HIV-associated Kaposi sarcoma. Cancer Cell Int., 8, 14.
31. Rusnati,M. and Presta,M. (2002) HIV-1 Tat protein and endothelium: from protein/cell interaction to AIDS-associated pathologies. Angiogenesis, 5, 141-151.
32. Ensoli,B., Gendelman,R., Markham,P., Fiorelli,V., Colombini,S., Raffeld,M., Cafaro,A., Chang,H.K., Brady,J.N. and Gallo,R.C. (1994) Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature, 371, 674-680.
33. Zeng,Y., Zhang,X., Huang,Z., Cheng,L., Yao,S., Qin,D., Chen,X., Tang,Q., Lv,Z., Zhang,L. et al. (2007) Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus: role of JAK/STAT signaling. J. Virol., 81, 2401-2417.
34. Guo,H.G., Pati,S., Sadowska,M., Charurat,M. and Reitz,M. (2004) Tumorigenesis by human herpesvirus 8 vGPCR is accelerated by human immunodeficiency virus type 1 Tat. J. Virol., 78, 9336-9342.
35. Chen,X., Cheng,L., Jia,X., Zeng,Y., Yao,S., Lv,Z., Qin,D., Fang,X., Lei,Y. and Lu,C. (2009) Human immunodeficiency virus type 1 Tat accelerates Kaposi sarcoma-associated herpesvirus Kaposin A-mediated tumorigenesis of transformed fibroblasts in vitro as well as in nude and immunocompetent mice. Neoplasia, 11, 1272-1284.
36. Barillari,G. and Ensoli,B. (2002) Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma. Clin. Microbiol. Rev, 15, 310-326.
37. Edgell,C.J., McDonald,C.C. and Graham,J.B. (1983) Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. U.S.A., 80, 3734-3737.
38. Xue,M., Yao,S., Hu,M., Li,W., Hao,T., Zhou,F., Zhu,X., Lu,H., Qin,D., Yan,Q. et al. (2014) HIV-1 Nef and KSHV oncogene K1 synergistically promote angiogenesis by inducing cellular miR-718 to regulate the PTEN/AKT/mTOR signaling pathway. Nucleic Acids Res., 42, 9862-9879.
39. Wada,Y., Otu,H., Wu,S., Abid,M.R., Okada,H., Libermann,T., Kodama,T., Shih,S.C., Minami,T. and Aird,W.C. (2005) Preconditioning of primary human endothelial cells with inflammatory mediators alters the "set point" of the cell. FASEB J., 19, 1914-1916.
40. Tang,Q., Qin,D., Lv,Z., Zhu,X., Ma,X., Yan,Q., Zeng,Y., Guo,Y., Feng,N. and Lu,C. (2012) Herpes simplex virus type 2 triggers reactivation of Kaposi's sarcoma-associated herpesvirus from latency and collaborates with HIV-1 Tat. PLoS One, 7, e31652.
41. Lei,X., Bai,Z., Ye,F., Xie,J., Kim,C.G., Huang,Y. and Gao,S.J. (2010) Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA. Nat. Cell Biol., 12, 193-199.
42. Aranda,E. and Owen,G.I. (2009) A semi-quantitative assay to screen for angiogenic compounds and compounds with angiogenic potential using the EA.hy926 endothelial cell line. Biol. Res., 42, 377-389.
43. Ebert,M.S., Neilson,J.R. and Sharp,P.A. (2007) MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Methods, 4, 721-726.
44. Yan,Q., Ma,X., Shen,C., Cao,X., Feng,N., Qin,D., Zeng,Y., Zhu,J., Gao,S.J. and Lu,C. (2014) Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular MicroRNA hsa-miR-1258. J. Virol., 88, 4987-5000.
45. Yan,Q., Li,W., Tang,Q., Yao,S., Lv,Z., Feng,N., Ma,X., Bai,Z., Zeng,Y., Qin,D. et al. (2013) Cellular microRNAs 498 and 320d regulate herpes simplex virus 1 induction of Kaposi's sarcoma-associated herpesvirus lytic replication by targeting RTA. PLoS One, 8, e55832.
46. Qin,D., Feng,N., Fan,W., Ma,X., Yan,Q., Lv,Z., Zeng,Y., Zhu,J. and Lu,C. (2011) Activation of PI3K/AKT and ERK MAPK signal pathways is required for the induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1. BMC Microbiol., 11, 240.
47. Qin,D., Zeng,Y., Qian,C., Huang,Z., Lv,Z., Cheng,L., Yao,S., Tang,Q., Chen,X. and Lu,C. (2008) Induction of lytic cycle replication of Kaposi's sarcoma-associated herpesvirus by herpes simplex virus type 1: involvement of IL-10 and IL-4. Cell Microbiol., 10, 713-728.
48. Zhu,X., Zhou,F., Qin,D., Zeng,Y., Lv,Z., Yao,S. and Lu,C. (2011) Human immunodeficiency virus type 1 induces lytic cycle replication of Kaposi's-sarcoma-associated herpesvirus: role of Ras/c-Raf/MEK1/2, PI3K/AKT, and NF-kappaB signaling pathways. J. Mol. Biol., 410, 1035-1051.
49. Kim,S., Domon-Dell,C., Kang,J., Chung,D.H., Freund,J.N. and Evers,B.M. (2004) Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-alpha/nuclear factor-kappaB (NF-kappaB)-inducing kinase/NF-kappaB pathway is linked to a default IkappaB-alpha autoregulatory loop. J. Biol. Chem., 279, 4285-4291.
50. Du,L., Wang,H., He,L., Zhang,J., Ni,B., Wang,X., Jin,H., Cahuzac,N., Mehrpour,M., Lu,Y. et al. (2008) CD44 is of functional importance for colorectal cancer stem cells. Clin. Cancer Res., 14, 6751-6760.
51. Keller,S.A., Hernandez-Hopkins,D., Vider,J., Ponomarev,V., Hyjek,E., Schattner,E.J. and Cesarman,E. (2006) NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo. Blood, 107, 3295-3302.
52. da Silva,S.R. and de Oliveira,D.E. (2011) HIV, EBV and KSHV: viral cooperation in the pathogenesis of human malignancies. Cancer Lett., 305, 175-185.
53. Samaniego,F., Pati,S., Karp,J.E., Prakash,O. and Bose,D. (2001) Human herpesvirus 8 K1-associated nuclear factor-kappa B-dependent promoter activity: role in Kaposi's sarcoma inflammation? J. Natl. Cancer Inst. Monogr., 15-23.
54. Ray,P.E., Al-Attar,A., Liu,X.H., Das,J.R., Tassi,E. and Wellstein,A. (2014) Expression of a secreted fibroblast growth factor binding protein-1 (FGFBP1) in angioproliferative Kaposi sarcoma. J. AIDS Clin. Res., 5, 309.
55. Xu,Q., Briggs,J., Park,S., Niu,G., Kortylewski,M., Zhang,S., Gritsko,T., Turkson,J., Kay,H., Semenza,G.L. et al. (2005) Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways. Oncogene, 24, 5552-5560.
56. Cavallin,L.E., Goldschmidt-Clermont,P. and Mesri,E.A. (2014) Molecular and cellular mechanisms of KSHV oncogenesis of Kaposi's sarcoma associated with HIV/AIDS. PLoS Pathog., 10, e1004154.
57. Harrington,W. Jr., Sieczkowski,L., Sosa,C., Chan-a-Sue,S., Cai,J.P., Cabral,L. and Wood,C. (1997) Activation of HHV-8 by HIV-1 tat. Lancet, 349, 774-775.
58. Sui,Z., Sniderhan,L.F., Fan,S., Kazmierczak,K., Reisinger,E., Kovacs,A.D., Potash,M.J., Dewhurst,S., Gelbard,H.A. and Maggirwar,S.B. (2006) Human immunodeficiency virus-encoded Tat activates glycogen synthase kinase-3beta to antagonize nuclear factor-kappaB survival pathway in neurons. Eur. J. Neurosci., 23, 2623-2634.
59. Prakash,O., Swamy,O.R., Peng,X., Tang,Z.Y., Li,L., Larson,J.E., Cohen,J.C., Gill,J., Farr,G., Wang,S. et al. (2005) Activation of Src kinase Lyn by the Kaposi sarcoma-associated herpesvirus K1 protein: implications for lymphomagenesis. Blood, 105, 3987-3994.
60. Ensoli,B., Buonaguro,L., Barillari,G., Fiorelli,V., Gendelman,R., Morgan,R.A., Wingfield,P. and Gallo,R.C. (1993) Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J. Virol., 67, 277-287.
61. Selby,M.J., Bain,E.S., Luciw,P.A. and Peterlin,B.M. (1989) Structure, sequence, and position of the stem-loop in tar determine transcriptional elongation by tat through the HIV-1 long terminal repeat. Genes Dev., 3, 547-558.
62. Field,N., Low,W., Daniels,M., Howell,S., Daviet,L., Boshoff,C. and Collins,M. (2003) KSHV vFLIP binds to IKK-gamma to activate IKK. J. Cell Sci., 116, 3721-3728.
63. Sun,Q., Matta,H., Lu,G. and Chaudhary,P.M. (2006) Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-kappaB activation. Oncogene, 25, 2717-2726.
64. Havemeier,A., Gramolelli,S., Pietrek,M., Jochmann,R., Sturzl,M. and Schulz,T.F. (2014) Activation of NF-kappaB by the Kaposi's sarcoma-associated herpesvirus K15 protein involves recruitment of the NF-kappaB-inducing kinase, IkappaB kinases, and phosphorylation of p65. J. Virol., 88, 13161-13172.
65. Brinkmann,M.M., Glenn,M., Rainbow,L., Kieser,A., Henke-Gendo,C. and Schulz,T.F. (2003) Activation of mitogen-activated protein kinase and NF-kappaB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein. J. Virol., 77, 9346-9358.
66. Pati,S., Cavrois,M., Guo,H.G., Foulke,J.S. Jr, Kim,J., Feldman,R.A. and Reitz,M. (2001) Activation of NF-kappaB by the human herpesvirus 8 chemokine receptor ORF74: evidence for a paracrine model of Kaposi's sarcoma pathogenesis. J. Virol., 75, 8660-8673.
67. Seo,T., Park,J., Lim,C. and Choe,J. (2004) Inhibition of nuclear factor kappaB activity by viral interferon regulatory factor 3 of Kaposi's sarcoma-associated herpesvirus. Oncogene, 23, 6146-6155.
68. Konrad,A., Wies,E., Thurau,M., Marquardt,G., Naschberger,E., Hentschel,S., Jochmann,R., Schulz,T.F., Erfle,H., Brors,B. et al. (2009) A systems biology approach to identify the combination effects of human herpesvirus 8 genes on NF-kappaB activation. J. Virol., 83, 2563-2574.
69. Lee,B.S., Paulose-Murphy,M., Chung,Y.H., Connlole,M., Zeichner,S. and Jung,J.U. (2002) Suppression of tetradecanoyl phorbol acetate-induced lytic reactivation of Kaposi's sarcoma-associated herpesvirus by K1 signal transduction. J. Virol., 76, 12185-12199.
70. de Oliveira,D.E., Ballon,G. and Cesarman,E. (2010) NF-kappaB signaling modulation by EBV and KSHV. Trends Microbiol., 18, 248-257.
71. Sadagopan,S., Sharma-Walia,N., Veettil,M.V., Raghu,H., Sivakumar,R., Bottero,V. and Chandran,B. (2007) Kaposi's sarcoma-associated herpesvirus induces sustained NF-kappaB activation during de novo infection of primary human dermal microvascular endothelial cells that is essential for viral gene expression. J. Virol., 81, 3949-3968.
72. Keller,S.A., Schattner,E.J. and Cesarman,E. (2000) Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood, 96, 2537-2542.
73. Brown,H.J., Song,M.J., Deng,H., Wu,T.T., Cheng,G. and Sun,R. (2003) NF-kappaB inhibits gammaherpesvirus lytic replication. J. Virol., 77, 8532-8540.
74. Sivakumar,R., Sharma-Walia,N., Raghu,H., Veettil,M.V., Sadagopan,S., Bottero,V., Varga,L., Levine,R. and Chandran,B. (2008) Kaposi's sarcoma-associated herpesvirus induces sustained levels of vascular endothelial growth factors A and C early during in vitro infection of human microvascular dermal endothelial cells: biological implications. J. Virol., 82, 1759-1776.
75. Greene,W., Kuhne,K., Ye,F., Chen,J., Zhou,F., Lei,X. and Gao,S.J. (2007) Molecular biology of KSHV in relation to AIDS-associated oncogenesis. Cancer Treat. Res., 133, 69-127.
76. Esquela-Kerscher,A. and Slack,F.J. (2006) Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer, 6, 259-269.
77. Gregory,R.I. and Shiekhattar,R. (2005) MicroRNA biogenesis and cancer. Cancer Res., 65, 3509-3512.
78. Feng,X., Wang,H., Ye,S., Guan,J., Tan,W., Cheng,S., Wei,G., Wu,W., Wu,F. and Zhou,Y. (2012) Up-regulation of microRNA-126 may contribute to pathogenesis of ulcerative colitis via regulating NF-kappaB inhibitor IkappaBalpha. PLoS One, 7, e52782.
79. Jiang,L., Lin,C., Song,L., Wu,J., Chen,B., Ying,Z., Fang,L., Yan,X., He,M., Li,J. et al. (2012) MicroRNA-30e∗ promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-kappaB/IkappaBalpha negative feedback loop. J. Clin. Invest., 122, 33-47.
80. Huang,F., Tang,J., Zhuang,X., Zhuang,Y., Cheng,W., Chen,W., Yao,H. and Zhang,S. (2014) MiR-196a promotes pancreatic cancer progression by targeting nuclear factor kappa-B-inhibitor alpha. PLoS One, 9, e87897.
81. Moody,R., Zhu,Y., Huang,Y., Cui,X., Jones,T., Bedolla,R., Lei,X., Bai,Z. and Gao,S.J. (2013) KSHV microRNAs mediate cellular transformation and tumorigenesis by redundantly targeting cell growth and survival pathways. PLoS Pathog., 9, e1003857.
82. Ye,S.B., Li,Z.L., Luo,D.H., Huang,B.J., Chen,Y.S., Zhang,X.S., Cui,J., Zeng,Y.X. and Li,J. (2014) Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget, 5, 5439-5452.
83. Zha,R., Guo,W., Zhang,Z., Qiu,Z., Wang,Q., Ding,J., Huang,S., Chen,T., Gu,J., Yao,M. et al. (2014) Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin beta1 in hepatocellular carcinoma. PLoS One, 9, e87665.